Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • blackknight
    Junior Member
    • Feb 2014
    • 2

    GUIDE-seq oligo design

    Hi everyone,

    I am trying to understand how the primers were designed for the GUIDE-seq protocol:

    GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases


    The protocol states that I should use either sense or antisense primers, but it looks like to me that if I only use the sense primers I will get a very small PCR product only containing the ODN and other parts of the oligo and no information about the sequence next to the ODN.

    To me it looks like that GSP1-sense does not fit with the GSP2-sense primer. The GSP1-sense primer aligns with the GSP2-anti oligo.

    Can anyone explain how it works? I have attached a PDF of my alignments.

    Thanks,

    Anders
    Attached Files
  • captainentropy
    Member
    • Mar 2009
    • 89

    #2
    You'll capture DNA adjacent to one-side of the oligo integration site whichever direction you choose to use. We went with the negative strand primer as GSP1(-) will have a longer contact with the ODN (29 bases vs. 22). Our thinking was the longer stretch will be marginally more stable and thus improve the capture. But we got good data with the (+) as well.

    I need to write things out to see what's going on with these types of assays so here's what I was constructed. I think it's accurate, so if you find an error just PM me.
    Attached Files

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 12:17 PM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    37 views
    0 reactions
    Last Post SEQadmin2  
    Working...